Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02021617
NA

Infusion Flow Rates and Blood Sampling

Sponsor: Vidacare Corporation

View on ClinicalTrials.gov

Summary

* To evaluate infusion flow rates attainable when using the proximal humerus and proximal tibia IO vascular access sites. * To evaluate the intraosseous infusion physiology when using the proximal humerus and proximal tibia IO infusion sites. * To further evaluate the relationship between IO and venous blood when used for laboratory testing. * To determine the time from IO needle insertion to IO access established.

Official title: A Study Comparing Infusion Flow Rates Using the Proximal Humerus and Proximal Tibia Intraosseous Vascular Access Insertion Sites and Comparing Intraosseous and Venous Blood for Laboratory Specimen Sampling

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2013-11-05

Completion Date

2013-11-15

Last Updated

2026-10-14

Healthy Volunteers

Yes

Interventions

DEVICE

Intraosseous access

The EZ-IO Intraosseous Vascular Access System (Vidacare Corporation, Shavano Park, TX, USA) has been cleared by the U.S. Food and Drug Administration, Health Canada, and the European Union for the administration of drugs and fluids anytime vascular access is difficult to obtain in emergent, urgent, or medically necessary cases. It consists of a driver-a small battery-powered drill-and a needle set designed for insertion into the IO space of the proximal tibia, distal tibia, or proximal humerus. Needles are 15 gauge and available in three lengths: 15 mm, 25 mm, and 45 mm. In this study the 45 mm EZ-IO needle set will be used for all humeral placements and the 25 mm needle set will be used for all tibial placements.

Locations (1)

Bulverde Spring Branch EMS

Spring Branch, Texas, United States